• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Establishment of a novel predictive index for the progression of cerebro-heart renal involvement in lifestyle-related diseases focusing on monocyte and microglial functions

Research Project

Project/Area Number 19K07905
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 52010:General internal medicine-related
Research InstitutionDepartment of Clinical Research, National Hospital Organization Kyoto Medical Center

Principal Investigator

Yamakage Hajime  独立行政法人国立病院機構(京都医療センター臨床研究センター), 内分泌代謝高血圧研究部, 研究員 (40598900)

Co-Investigator(Kenkyū-buntansha) 浅原 哲子 (佐藤哲子)  独立行政法人国立病院機構(京都医療センター臨床研究センター), 内分泌代謝高血圧研究部, 研究部長 (80373512)
Project Period (FY) 2019-04-01 – 2023-03-31
Project Status Completed (Fiscal Year 2022)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2021: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
KeywordsTREM2 / 脳心腎連関 / 糖尿病 / 肥満 / 早期予知バイオマーカー / 治療戦略 / 単球・ミクログリア
Outline of Research at the Start

肥満症・糖尿病/一般住民コホートにて、炎症・単球機能(M1/M2・TREM2)と脳心腎連関進展との関連を検討する。さらに、臨床研究成績を裏付ける基礎検討として、TREM2欠損マウス、肥満・糖尿病及び腎不全モデルマウスにて、脳・心臓・腎臓における炎症状態や単球・Mφ活性化レベル・TREM2発現、血清sTREM2レベルを明らかにし、脳心腎連関における
M1/M2極性・TREM2の病態意義を明らかにする。

Outline of Final Research Achievements

This study showed that high blood sTREM2 levels were associated with cognitive decline in diabetic patients in the National Hospital Organization Multicenter Diabetes and Obesity Cohort. We also reported that in the non-obese diabetic HbA1c exacerbation group, initially high levels of sTREM2 were significantly associated with cognitive decline at 2 years, and that sTREM2 is a novel predictive indicator of cognitive decline. We also observed that a decrease over time in eGFRcys, converted by cystatin C, was associated with the development of CVD. Furthermore, we reported that SGLT2 inhibitors improved renal function. We also reported the characteristics of diabetic dementia focusing on TREM2 in a newly constructed cohort of dementia and mild cognitive impairment.

Academic Significance and Societal Importance of the Research Achievements

本研究において、多施設肥満症・糖尿病コホートと認知症コホートを基盤に、肥満・糖尿病における認知症・腎症進展における単球・ミクログリア機能・sTREM2の病態意義について報告した。今後さらに、糖尿病・肥満症の脳心腎連関アウトカム・リスクに対する血中sTREM2との関連解析、糖尿病・肥満の有無別、薬物治療別などのサブ解析を行い、TREM2に着目した脳心腎連関進展予防戦略を提案する。特に未だ詳細が解明されていない肥満の認知症への影響、糖尿病性腎症及び認知症の病態・特徴を明らかにし、糖尿病・肥満症に伴う脳心腎連関進展における革新的な早期診断法・高リスク群抽出法と先制医療の構築を目指す。

Report

(5 results)
  • 2022 Annual Research Report   Final Research Report ( PDF )
  • 2021 Research-status Report
  • 2020 Research-status Report
  • 2019 Research-status Report
  • Research Products

    (17 results)

All 2023 2022 2021 2020 2019

All Journal Article (10 results) (of which Int'l Joint Research: 3 results,  Peer Reviewed: 9 results,  Open Access: 9 results) Presentation (7 results)

  • [Journal Article] Novel Therapeutic Potentials of Taxifolin for Obesity-Induced Hepatic Steatosis, Fibrogenesis, and Tumorigenesis2023

    • Author(s)
      Inoue Takayuki、Fu Bin、Nishio Miwako、Tanaka Miyako、Kato Hisashi、Tanaka Masashi、Itoh Michiko、Yamakage Hajime、Ochi Kozue、Ito Ayaka、Shiraki Yukihiro、Saito Satoshi、Ihara Masafumi、Nishimura Hideo、Kawamoto Atsuhiko、Inoue Shian、Saeki Kumiko、Enomoto Atsushi、Suganami Takayoshi、Satoh-Asahara Noriko
    • Journal Title

      Nutrients

      Volume: 15 Issue: 2 Pages: 350-350

    • DOI

      10.3390/nu15020350

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Cystatin C-based eGFR predicts cardiovascular disease in patients with overweight/obesity and hyperglycemia2022

    • Author(s)
      Suzuki K, Tsujiguchi H, Hara A, Nakamura H, Kotani K, Noda M, Yamakage H, Satoh-Asahara N, Takamura T
    • Journal Title

      Obes Sci Pract

      Volume: 9 Issue: 1 Pages: 4-14

    • DOI

      10.1002/osp4.630

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Analysis of time-dependent changes in the FIB4 index in patients with obesity receiving weight reduction therapy2022

    • Author(s)
      Kawai Shiori、Yamakage Hajime、Kotani Kazuhiko、Noda Mitsuhiko、Satoh-Asahara Noriko、Hashimoto Koshi
    • Journal Title

      Scientific Reports

      Volume: 12 Issue: 1 Pages: 15219-15219

    • DOI

      10.1038/s41598-022-19420-0

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Soluble TREM2 and Alzheimer-related biomarker trajectories in the blood of patients with diabetes based on their cognitive status2022

    • Author(s)
      Satoh-Asahara Noriko、Yamakage Hajime、Tanaka Masashi、Kawasaki Teruaki、Matsuura Sayo、Tatebe Harutsugu、Akiguchi Ichiro、Tokuda Takahiko
    • Journal Title

      Diabetes Research and Clinical Practice

      Volume: 193 Pages: 110121-110121

    • DOI

      10.1016/j.diabres.2022.110121

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Higher Serum Soluble TREM2 as a Potential Indicative Biomarker for Cognitive Impairment in Inadequately Controlled Type 2 Diabetes Without Obesity: The DOR-KyotoJ-12022

    • Author(s)
      Tanaka Masashi、Yamakage Hajime、Satoh-Asahara Noriko、et al
    • Journal Title

      Frontiers in Endocrinology

      Volume: 13 Pages: 880148-880148

    • DOI

      10.3389/fendo.2022.880148

    • Related Report
      2022 Annual Research Report 2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Association of daily sleep duration with the incident dementia by serum soluble <scp>TREM2</scp> in a community2021

    • Author(s)
      Ohara Tomoyuki、Hata Jun、Tanaka Masashi、Honda Takanori、Yamakage Hajime、Inoue Takayuki、Hirakawa Yoichiro、Kusakabe Toru、Shibata Mao、Kitazono Takanari、Nakao Tomohiro、Satoh‐Asahara Noriko、Ninomiya Toshiharu
    • Journal Title

      Journal of the American Geriatrics Society

      Volume: 70 Issue: 4 Pages: 1147-1156

    • DOI

      10.1111/jgs.17634

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] TREM22021

    • Author(s)
      浅原 哲子、田中 将志、山陰 一、井上 隆之
    • Journal Title

      老年内科

      Volume: 3 Pages: 739-748

    • NAID

      40022630992

    • Related Report
      2021 Research-status Report
  • [Journal Article] Beneficial Effects of Ipragliflozin on the Renal Function and Serum Uric Acid Levels in Japanese Patients with Type 2 Diabetes: A Randomized, 12-week, Open-label, Active-controlled Trial2020

    • Author(s)
      Tanaka Masashi、Yamakage Hajime、Inoue Takayuki、Odori Shinji、Kusakabe Toru、Shimatsu Akira、Satoh-Asahara Noriko
    • Journal Title

      Internal Medicine

      Volume: 59 Issue: 5 Pages: 601-609

    • DOI

      10.2169/internalmedicine.3473-19

    • NAID

      130007804618

    • ISSN
      0918-2918, 1349-7235
    • Year and Date
      2020-03-01
    • Related Report
      2020 Research-status Report 2019 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy2019

    • Author(s)
      Inoue Takayuki、Saito Satoshi、Tanaka Masashi、Yamakage Hajime、Kusakabe Toru、Shimatsu Akira、Ihara Masafumi、Satoh-Asahara Noriko
    • Journal Title

      Proceedings of the National Academy of Sciences

      Volume: 116 Issue: 20 Pages: 10031-10038

    • DOI

      10.1073/pnas.1901659116

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Effects of dapagliflozin on the serum levels of fibroblast growth factor?21 and myokines and muscle mass in Japanese patients with type?2 diabetes: A randomized, controlled trial2019

    • Author(s)
      Yamakage Hajime、Tanaka Masashi、Inoue Takayuki、Odori Shinji、Kusakabe Toru、Satoh‐Asahara Noriko
    • Journal Title

      Journal of Diabetes Investigation

      Volume: none Issue: 3 Pages: 653-661

    • DOI

      10.1111/jdi.13179

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] 肥満症患者の5年間の減量成功率とCVDリスク改善効果-国立病院機構多施設コホート研究-2022

    • Author(s)
      岩佐真代、城嵩晶、山陰一、村中和哉、岩下香里、加藤久詞、加藤さやか、浅原哲子
    • Organizer
      第43回日本肥満学会・第40回日本肥満症治療学会学術集会
    • Related Report
      2022 Annual Research Report
  • [Presentation] 減量治療におけるMetabolically healthy obesityとMetabolically unhealthy obesityの比較検討2022

    • Author(s)
      川合汐里、山陰一、小谷和彦、野田光彦、浅原哲子、橋本貢士
    • Organizer
      第43回日本肥満学会・第40回日本肥満症治療学会学術集会
    • Related Report
      2022 Annual Research Report
  • [Presentation] 認知症・心血管病の早期評価系構築のための多施設共同大規模肥満症コホート研究2021

    • Author(s)
      山陰一、田中将志、井上隆之、村中和哉、和田啓道、長谷川浩二、日下部徹、浅原哲子
    • Organizer
      第41回日本肥満学会・第38回日本肥満症治療学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] 認知症・心血管病の早期評価系構築のための多施設共同大規模肥満症コホート研究2020

    • Author(s)
      山陰一、浅原哲子、JOMS/J-DOS2 Study Group
    • Organizer
      第5回日本糖尿病・生活習慣病ヒューマンデータ学会年次学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] 認知症発症予知因子・TREM2の脂肪組織における病態生理学的意義の解明2019

    • Author(s)
      井上隆之、田中将志、山陰一、村中和哉、池上健太郎、日下部徹、浅原哲子
    • Organizer
      第21回応用薬理シンポジウム
    • Related Report
      2019 Research-status Report
  • [Presentation] 生活習慣病における新規認知症予知バイオマーカー候補・sTREM2 の臨床的意義の検討2019

    • Author(s)
      山陰一、田中将志、井上隆之、村中和哉、和田啓道、長谷川浩二、日下部徹、浅原哲子
    • Organizer
      第40回日本肥満学会
    • Related Report
      2019 Research-status Report
  • [Presentation] 生活習慣病における新規認知機能低下予知バイオマーカー・sTREM2の臨床的意義の検討2019

    • Author(s)
      山陰 一、田中 将志、井上 隆之、村中 和哉、和田 啓道、長谷川 浩二、日下部 徹、浅原 哲子
    • Organizer
      第4回日本糖尿病・生活習慣病ヒューマンデータ学会年次学術集会
    • Related Report
      2019 Research-status Report

URL: 

Published: 2019-04-18   Modified: 2024-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi